- Home
- MGIC vs BEATW Comparison
MGIC vs BEATW Comparison
Compare MGIC & BEATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- BEATW
- Stock Information
- Founded
- MGIC 1983
- BEATW N/A
- Country
- MGIC Israel
- BEATW United States
- Employees
- MGIC N/A
- BEATW 20
- Industry
- MGIC Computer Software: Prepackaged Software
- BEATW Retail: Computer Software & Peripheral Equipment
- Sector
- MGIC Technology
- BEATW Technology
- Exchange
- MGIC Nasdaq
- BEATW Nasdaq
- Market Cap
- MGIC N/A
- BEATW N/A
- IPO Year
- MGIC 1991
- BEATW 2021
- Fundamental
- Price
- MGIC $11.89
- BEATW $0.60
- Analyst Decision
- MGIC Buy
- BEATW
- Analyst Count
- MGIC 1
- BEATW 0
- Target Price
- MGIC $15.00
- BEATW N/A
- AVG Volume (30 Days)
- MGIC 44.1K
- BEATW N/A
- Earning Date
- MGIC 11-18-2024
- BEATW N/A
- Dividend Yield
- MGIC 1.70%
- BEATW N/A
- EPS Growth
- MGIC N/A
- BEATW N/A
- EPS
- MGIC 0.70
- BEATW N/A
- Revenue
- MGIC $535,482,999.00
- BEATW N/A
- Revenue This Year
- MGIC $4.29
- BEATW N/A
- Revenue Next Year
- MGIC $3.39
- BEATW N/A
- P/E Ratio
- MGIC $17.20
- BEATW N/A
- Revenue Growth
- MGIC N/A
- BEATW N/A
- 52 Week Low
- MGIC $9.38
- BEATW N/A
- 52 Week High
- MGIC $13.40
- BEATW N/A
- Technical
- Relative Strength Index (RSI)
- MGIC 51.98
- BEATW N/A
- Support Level
- MGIC $11.51
- BEATW N/A
- Resistance Level
- MGIC $12.24
- BEATW N/A
- Average True Range (ATR)
- MGIC 0.28
- BEATW 0.00
- MACD
- MGIC -0.07
- BEATW 0.00
- Stochastic Oscillator
- MGIC 43.86
- BEATW 0.00
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.